Evidence Building
How to Document Collaborative Grants as O-1A Critical Role Evidence When the Petitioner Is a Co-Investigator Rather Than the Lead PI
Being a co-investigator rather than a lead PI on a federal grant does not disqualify a researcher from meeting the O-1A critical role criterion. This guide explains how to document sub-aim responsibility, effort allocation, and expert declarations to satisfy the requirement.
The critical role criterion for research petitioners
The O-1A critical role criterion under 8 C.F.R. § 214.2(o)(3)(iv)(A) requires evidence that the petitioner has performed in a critical or essential role for organizations or establishments that have a distinguished reputation. For research scientists, the organization is typically a university, research institute, federal laboratory, or distinguished collaborative research program, and the critical role is documented through their specific contributions to the research mission. The criterion is satisfied when the petitioner's role was necessary to the organization's success in a recognized function, not merely when the petitioner was employed there. An entry-level staff scientist who performed routine work at a distinguished laboratory does not satisfy the critical role criterion by association; a co-investigator who designed the experimental framework for a multi-institutional grant that produced the laboratory's signature findings stands on substantially stronger ground.
The co-investigator role in a multi-institutional grant creates a specific evidentiary challenge. On the I-129 petition, the petitioner must demonstrate both that the grant program was distinguished and that their specific role within it was critical. The first is usually straightforward: federal research grants from NIH, NSF, DOE, DOD, or NASA carry institutional credibility, and the funding level, competitive peer review, and principal investigator credentials provide easy benchmarks for the program's distinction. The second is harder, because co-investigator credit on a grant differs fundamentally from named-author credit on a publication. The grant's budget and funding agency establish the program's significance; the petitioner's specific role within it must be established through separate documentation.
USCIS officers reviewing O-1A petitions have increasingly recognized that research is a collaborative enterprise and that major contributions frequently happen within multi-investigator teams. The AAO has sustained critical role findings for researchers who occupied specific and non-redundant roles within large collaborative programs — particularly when the role involved unique expertise that the program could not have obtained from other sources. The key argument is non-fungibility: the petitioner's role was not simply one of many interchangeable positions, but a specific function that their specialized expertise enabled and that others on the team could not readily have performed.
What the regulation requires
The phrase critical or essential distinguishes the O-1A criterion from simply being employed in a notable position. USCIS uses the terms interchangeably in practice, but both carry the implication that the role was not peripheral to the organization's mission. For a co-investigator on a collaborative grant, this means the exhibit must demonstrate that the specific aims for which the co-investigator was responsible were central to the grant's overall scientific goals — not ancillary tasks that would have been completed with or without the co-investigator's involvement.
The organization must have a distinguished reputation. For federal research grants, the distinction is established through the funding agency's recognition: an NIH R01, an NSF CAREER award, a DOE Early Career Award, or a DARPA program grant each carries a recognized level of competitive selectivity that USCIS officers can reference. Multi-institutional center grants — NIH P50 or P30 center grants, NSF Science and Technology Center grants, or DOE Energy Frontier Research Centers — add a layer of institutional distinction beyond the individual grant, because center grants represent recognized investments in sub-field infrastructure rather than individual projects.
The has performed language requires past performance: the petitioner must have already played the critical role, not merely be expected to. For recent grants, this means the exhibit should document the petitioner's actual contributions rather than their intended future contributions. Publications, datasets, reports to the funding agency, or presentations made in the capacity of the co-investigator role provide the documented record of past performance. A grant award letter alone, without evidence of actual contribution, is insufficient; it demonstrates that the petitioner was selected for the role but not that they performed it.
Evidence that routinely satisfies the criterion for co-investigators
The strongest documentary foundation for a co-investigator critical role exhibit is the Notice of Award combined with the specific aims page showing the petitioner's sub-aims and a declaration from the lead PI explaining what the co-investigator was responsible for and why their specific expertise was required. The Notice of Award identifies the petitioner by name as a co-investigator, establishes the funding agency and award amount, and provides a date-stamped record of formal recognition. The specific aims page situates the petitioner's sub-aims within the overall scientific goals. The lead PI declaration — which functions as an expert letter in this context — explains the non-fungibility of the petitioner's contribution.
The salary or effort allocation on the grant budget provides quantitative evidence of role significance. A co-investigator with twenty percent or more effort allocated in the funded grant represents a substantial investment of the research team's resources on that individual's contributions. Budget documents showing the effort allocation, combined with a statement explaining what that effort produced, demonstrate that the grant's funding agency reviewed and approved the petitioner's level of contribution as necessary. If progress reports to the funding agency acknowledge the co-investigator's specific contributions, those reports provide contemporaneous third-party documentation from the funding agency's oversight perspective.
Publications arising from the grant that name the petitioner as a co-author provide the most concrete evidence of actual contribution. For a co-investigator exhibit, the publications should be annotated to show which grant funded them — typically visible in the acknowledgments section — and any author contribution statements or footnotes that specify the petitioner's methodological or conceptual role should be highlighted. A petitioner who is corresponding author on publications arising from their sub-aims, even within a grant led by another PI, has demonstrated that the funding agency and the scientific community recognized their sub-aim as independently significant.
Evidence USCIS regularly discounts
A grant listing that shows the petitioner's name without role specification is insufficient. Federal grants list investigators in agency databases such as NIH's Reporter, and a simple printout showing the petitioner's name alongside several other investigators tells an officer nothing about which occupied critical roles and which served supporting functions. The exhibit must identify the specific sub-aims, budget allocation, and publications attributable to the petitioner's co-investigator contribution; a listing without these specifics fails to distinguish the critical role from an incidental one.
Subcontract relationships on federal grants present a related challenge. A researcher at Institution B who holds a subcontract funded by Institution A's prime award is technically a co-investigator in the collaborative sense, but the subcontract structure may make their role appear secondary. The exhibit must explain the collaborative structure explicitly: that the overall program required the petitioner's expertise, that the subcontract budget allocated to the petitioner's work reflects a major portion of the program's resources, and that the petitioner's sub-aims were peer-reviewed as part of the prime award application. A letter from the prime awardee's PI confirming the petitioner's critical role supplements the formal documentation.
Letter-of-support contributions — where a faculty member signs a letter attached to another investigator's grant but has no budget allocation, no specific aims, and no formal role — should not be submitted as co-investigator evidence. An officer who notices that the petitioner received no salary support and had no budget line in the grant will likely conclude that the co-investigator designation is nominal rather than substantive. These nominal affiliations, presented without clarification, can undermine an otherwise strong petition by making the petitioner's actual roles appear inflated.
How to present borderline evidence
When the petitioner's co-investigator role was significant but the grant documentation does not clearly distinguish their contribution from others', the exhibit must build significance through the expert declaration framework. The lead PI should describe specifically what would have happened to the grant's scientific aims if the petitioner had not been available — not as hypothetical advocacy, but as a concrete explanation of the scientific dependency. If the co-investigator developed a unique assay, model system, or analytical method that other team members relied on, the lead PI can explain that dependency specifically and name the aims that depended on the petitioner's particular contribution.
For grants that have concluded, the final progress report or technical report to the funding agency provides an independent record of what was accomplished during the grant period. These documents are written for the funding agency's programmatic officers, not for immigration purposes, which makes them more credible as contemporaneous records of actual performance. If the final report acknowledges the co-investigator's specific contributions, that acknowledgment comes from the lead PI's own contemporaneous report to the agency — a declaration that predates the immigration petition and therefore carries stronger evidentiary weight than a letter written specifically for USCIS review.
For early-career researchers who served as co-investigators on smaller awards or pilot grants while developing their independent programs, the exhibit should contextualize the grant size within the career stage. A co-investigator role on a competitive NIH R21 pilot grant may appear modest compared to a fully-funded R01, but for a researcher at the assistant professor stage it is a marker of recognized expertise. The lead PI's declaration can frame this explicitly, noting that the competitive selection rate for the grant and the funding agency's investment in the co-investigator's specific aims reflects field recognition of the petitioner's expertise.
Building and auditing your co-investigator critical role exhibit
The complete co-investigator exhibit for the critical role criterion should include: the Notice of Award for each major grant, the specific aims page showing the petitioner's sub-aims, the budget and effort allocation showing the petitioner's funded percentage, publications arising from the grant with funding acknowledgments, any progress reports acknowledging the petitioner's specific contributions, and a declaration from the lead PI explaining the non-fungibility of the petitioner's role. Organize these materials by grant, with each grant's documentation presented as a unit, and summarize the overall picture in an introductory tab or cover page that identifies the program's distinction and the petitioner's specific contributions.
Before filing, verify that each Notice of Award correctly identifies the petitioner by name and role. Federal agency award databases may list investigators under their legal name, which may differ from the name used on publications; a brief note resolving any name discrepancy prevents an unnecessary RFE. Similarly, confirm that the effort allocation in the budget matches the role described in the expert declaration; an officer who sees a five percent effort allocation alongside a declaration describing a central role will find the discrepancy problematic.
Count the total grant funding on which the petitioner has served as a named co-investigator or principal investigator, and compare it to typical funding levels for researchers at the same career stage and institution type. A researcher who has been a named co-investigator on ten million dollars or more in federal research funding over a ten-year career is providing evidence of sustained significant contribution to distinguished programs, and that aggregate figure is itself meaningful. If the department chair or research office can provide a brief statement contextualizing the petitioner's funding record relative to peers at the institution, that statement strengthens the distinguished reputation argument.
What we typically gather for this kind of case
| Document | Where to source | Why it matters |
|---|---|---|
| Peer-reviewed publications | Web of Science / Scopus exports | Anchors original-contributions and authorship criteria |
| Citation analysis | Google Scholar profile + ESI top-1% data | Quantifies major significance in the field |
| Salary benchmark | BLS OEWS for SOC code + locality | Documents high-salary criterion at 90th-percentile or above |
| Critical-role letters | Direct supervisor + program director | Establishes role's importance, not just title |
What we see go wrong, again and again
- 01Treating extraordinary ability as a credentials checklist rather than a story of field-wide impact.
- 02Submitting bibliometric data (h-index, citation counts) without explaining what makes those numbers high relative to peers in the same sub-field.
- 03Relying on letters from collaborators or co-authors rather than independent experts who can speak to influence.
See if you qualify
Lando reviews your background against the O-1 visa criteria and tells you honestly where you stand. Free, no commitment.